The total number of social media users worldwide is estimated at around 5.24 billion,  which is roughly two-thirds of the global population*. Millions of patient, caregiver, APP & HCP conversations take place every day across social platforms, forums, communities, and AI platforms. For pharmaceutical brands preparing to launch or scale, these unfiltered discussions hold critical value. They reveal early warning signals, unmet needs, misconceptions, and opportunities to support patients better.

Social listening goes far beyond monitoring. When executed with the right combination of human expertise and advanced analytics, it becomes a strategic engine for shaping brand readiness and foreseeing future risks.

Below are three real-world examples showing how social listening delivered high-impact insights that transformed launch planning and protected brand reputation.

Case Study 1: Diverting a Crisis Before Launch

The Challenge

A U.S.-based pharmaceutical company preparing for a major product launch needed to better understand global perceptions of its brand and products. With large volumes of conversations happening across different languages and cultures, the organization risked missing early indicators of reputational threats that could jeopardize the launch.

The Approach

Our team developed a comprehensive global social listening strategy, including:

• Highly targeted search queries calibrated for accuracy
• Inclusion of regional idioms, slang, and cultural nuance
• Cross-market mapping to identify consistent themes and areas of concern

This enabled us to connect fragmented discussions into a cohesive view of global sentiment.

The Results

The analysis uncovered a critical insight: one of the company’s existing products was being linked to adverse events in multiple regions. With this knowledge, the brand proactively developed a crisis communication plan, addressing concerns early and mitigating potential harm. The company increased its launch readiness, strengthened stakeholder confidence, and avoided a possible crisis.

Case Study 2: Finding an Audience of 50 Out of 1,000,000

The Challenge

A global rare disease company preparing to launch a therapy for Acromegaly, affecting only 50 people per 1,000,000, needed to understand the needs of an extremely small, dispersed patient population. Traditional research channels couldn’t reveal the depth of lived experience required to shape an authentic, effective messaging strategy.

The Approach

We conducted a multi-layered analysis that began broad and then narrowed to highly specific conversations:

• Reviewing macro-level forums to isolate the micro-level forums where deep conversation were occurring.
• Isolating verified patient and advocate discussions
• Mapping connections between community members
• Filtering out irrelevant content to focus on genuine experiences

This approach ensured that even the quietest voices were heard.

The Results

The analysis revealed core concerns shaping patients’ quality of life, including:

• Burdensome travel to specialists
• Pain associated with ongoing treatment
• Deep anxiety about changes in physical appearance, especially among women

These insights became essential pillars for the brand’s messaging strategy, ensuring the launch communicated with empathy and relevance to a rare, underserved patient community.

Case Study 3: Addressing Misconceptions in NASH Ahead of Launch

The Challenge

A biopharmaceutical company launching a therapy for nonalcoholic steatohepatitis (NASH) needed clarity on widespread misconceptions that were limiting awareness, delaying diagnosis, and confusing patients. Without addressing these gaps, the launch risked low engagement and inadequate education.

The Approach

We analyzed patient and caregiver conversations across social platforms, forums, and support communities, focusing on:

• Misunderstandings about causes, symptoms, and risk factors
• Emotional patterns influencing decision-making
• Confusion between treatment options
• Over-reliance on lifestyle fixes or AI-driven self-diagnosis

By identifying both the misconceptions and the context behind them, we created a deeper understanding of the educational barriers.

The Results

The listening program uncovered several recurring misconceptions:

• Belief that fatty liver disease is caused only by alcohol
• Misperception that only older or overweight individuals are at risk
• Assumption that symptoms appear early
• Overconfidence in lifestyle changes as a cure
• Confusion driven by AI-generated health content

These findings empowered the brand to refine its launch messaging, correct misinformation, emphasize early screening, and position itself as a trusted source of patient education.

Why Social Listening Matters for Pharma Launches

These three case studies demonstrate the pivotal role social listening plays in bringing treatments to market:

• Risk mitigation: Identifying issues before they escalate
• Patient-centered insights: Understanding real-world experiences beyond clinical data
• Message refinement: Crafting communication that resonates
• Education and clarity: Correcting misconceptions that impact adoption
• Launch readiness: Empowering brands to move forward confidently

Social listening is no longer optional for pharma, it’s a strategic advantage. By combining human expertise with advanced analytics, brands gain visibility, intelligence, and foresight that shape stronger, safer, and more successful launches.

Resources:

Contact us to explore social listening/ moderation bundle

View our Moderation services page

Citation Source:

https://www.amraandelma.com/top-social-media-engagement-statistics/

/////

Reach out to the author, Rishi Kadiwar, VP Strategy, LiveWorld at rishi@liveworld.com